MedPath

Testing of the reliability of the Radner reading chart.

Completed
Conditions
maculopathy
10047060
macular degeneration
Registration Number
NL-OMON30878
Lead Sponsor
Oogziekenhuis Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

Maculopathy unchanged for a minimum of three months and progression within the next 3-4 weeks is unlikely.

Exclusion Criteria

Additional eye disease (eg. amblyopie) or medication (eg anxiolytica or anti-epileptica) that could affect reading performance,
(Suspected) dyslexia / illiteracy.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To analyze the test-retest and inter-chart reliability of the three charts of<br /><br>the Radner reading chart with respect to reading acuity, maximum reading speed<br /><br>and critical print size. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>If the Radner reading chart reveals to have a low reliability in this study<br /><br>population, new sentences have to be composed, tested and selected.</p><br>
© Copyright 2025. All Rights Reserved by MedPath